In 1992, Brugada and Brugada first described a new entity, which became known as 
Brugada syndrome, that is associated with a high risk of ventricular arrhythmias 
and sudden cardiac death in patients without structural heart disease. This 
syndrome is characterized by a distinct electrocardiographic phenotype, type 1 
Brugada pattern, consisting of a coved ST-segment elevation (≥0.2 mV) followed 
by a negative T wave in more than one right precordial lead. This pattern is 
dynamic, and can be spontaneous or concealed, but is unmasked under certain 
circumstances, like febrile states. The authors report a case in which the 
diagnosis of Brugada syndrome was made in the course of etiologic investigation 
of recurrent syncope in a febrile state.